Injections of a new drug may partially relieve paralyzing spinal cord injuries, based on indications from a study in rats, which was partly funded by the National Institutes of Health.
The results demonstrate how fundamental laboratory research may lead to new therapies.
“We’re very excited at the possibility that millions of people could, one day, regain movements lost during spinal cord injuries,” said Jerry Silver, Ph.D., professor of neurosciences, Case Western Reserve University School of Medicine, Cleveland, and a senior investigator of the study published in Nature.
Every year, tens of thousands of people are paralyzed by spinal cord injuries. The injuries crush and sever the long axons of spinal cord nerve cells, blocking communication between the brain and the body and resulting in paralysis below the injury.
On a hunch, Bradley Lang, Ph.D., the lead author of the study and a graduate student in Dr. Silver’s lab, came up with the idea of designing a drug that would help axons regenerate without having to touch the healing spinal cord, as current treatments may require.
“Originally this was just a side project we brainstormed in the lab,” said Dr. Lang.
After spinal cord injury, axons try to cross the injury site and reconnect with other cells but are stymied by scarring that forms after the injury. Previous studies suggested their movements are blocked when the protein tyrosine phosphatase sigma (PTP sigma), an enzyme found in axons, interacts with chondroitin sulfate proteoglycans, a class of sugary proteins that fill the scars.
Dr. Lang and his colleagues designed a drug called ISP to block the enzyme and facilitate the drug’s entry into the brain and spinal cord. Injections of the drug under the skin of paralyzed rats near the injury site partially restored axon growth and improved movements and bladder functions.
“There are currently no drug therapies available that improve the very limited natural recovery from spinal cord injuries that patients experience,” said Lyn Jakeman, Ph.D., a program director at the NIH’s National Institute of Neurological Disorders and Stroke, Bethesda, MD. “This is a great step towards identifying a novel agent for helping people recover.”
Initially, the goal of the study was to understand how interactions between PTP sigma and chondroitin sulfate proteoglycans prevent axon growth. Drugs were designed to mimic the shape of a critical part of PTP sigma, called the wedge. Different designs were tested on neurons grown in petri dishes alongside impenetrable barriers of proteoglycans. Treatment with ISP freed axon growth.
“It was amazing. The axons kept growing and growing,” said Dr. Silver.
The Latest on: Spinal cord injury
via Google News
The Latest on: Spinal cord injury
- Ryan Shazier feels “blessed,” so he helps other spinal cord patients get treatmenton February 24, 2021 at 12:36 pm
Steelers linebacker Ryan Shazier’s football career came to a sudden end when he suffered a serious spinal cord injury. But rather than viewing himself as unlucky to have encountered such a fate, ...
- New evidence stem cell therapy helps spinal injury patientson February 23, 2021 at 4:00 pm
A detailed analysis of 13 case histories has found intravenous injections of stem cells lead to substantial motor function improvements in patients suffering spinal cord injury. The research also ...
- Doctors might have figured out how to cure spinal cord injurieson February 23, 2021 at 4:00 pm
The worst type of spinal cord injuries can lead to permanent loss of sensory and motor function, meaning people will lose feeling below the region of the injury as well as movement. As it stands ...
- Evaluating patient perspectives on participating in scientific research and clinical trials for the treatment of spinal cord injuryon February 23, 2021 at 5:33 am
A questionnaire was developed to evaluate patients’ perspective on research aimed at improving functions and overcoming complications associated with spinal cord injury (SCI). T ...
- Scientists use patients' own stem cells to restore function after spinal cord injuryon February 22, 2021 at 3:49 pm
Intravenous injection of bone marrow derived stem cells (MSCs) in patients with spinal cord injuries led to significant improvement in motor functions, researchers from Yale University and Japan ...
- Massachusetts HS hockey player speaks publicly for first time since serious spinal cord injuryon February 21, 2021 at 6:18 am
In a video shared on Twitter, A.J. Quetta thanked everyone for their support, especially his teammates at Bishop Feehan High School.
- InVivo is up after peer-reviewed publication of study on spinal cord injuryon February 16, 2021 at 2:17 pm
InVivo Therapeutics is trading higher today in above-average volumeafter the company announcedthe publication of a peer-reviewed manuscript describing ...
- Assessment of neuropathic pain after spinal cord injury using quantitative pain drawingson February 16, 2021 at 12:14 pm
Clinimetric cross-sectional cohort study in adults with paraplegic spinal cord injury (SCI) and neuropathic pain (NP). Objective. To assess the reliability of standa ...
- Injury firm goes countrywide with new office openingon February 16, 2021 at 2:59 am
A serious injury claims specialist that started life in the north west has continued its expansion across the country with a new team hire. CFG Law today announced it will open a new office in Bury St ...
- Electrical Stimulation for Improved Function Post-Spinal Cord Injury: Interview with Dave Marver, CEO, ONWARDon February 10, 2021 at 1:59 pm
You may have seen an article Medgadget published recently about a minimally invasive neuromodulation technology that has shown significant promise in ...
via Bing News